These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29668450)

  • 1. Comorbidities of COPD in Bulgarian Patients - Prevalence and Association with Severity and Inflammation.
    Stratev V; Petkova D; Dimitrova V; Petev J
    Folia Med (Plovdiv); 2018 Mar; 60(1):102-109. PubMed ID: 29668450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic Syndrome as a Factor Affecting Systemic Inflammation in Patients with Chronic Obstructive Pulmonary Disease.
    Rubinsztajn R; Przybyłowski T; Maskey-Warzęchowska M; Paplińska-Goryca M; Nejman-Gryz P; Karwat K; Chazan R
    Adv Exp Med Biol; 2017; 1021():55-62. PubMed ID: 28382609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of comorbidities in COPD patients by disease severity in a German population.
    Greulich T; Weist BJD; Koczulla AR; Janciauskiene S; Klemmer A; Lux W; Alter P; Vogelmeier CF
    Respir Med; 2017 Nov; 132():132-138. PubMed ID: 29229085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence, associated factors, and clinical consequences of metabolic syndrome in chronic obstructive pulmonary disease patients: a 5-year prospective observational study.
    Keeratichananont W; Kaenmuang P; Geater SL; Manoret P; Thanapattaraborisuth B
    Ther Adv Respir Dis; 2023; 17():17534666231167342. PubMed ID: 37086118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Retrospective study on the prevalence of cardiovascular comorbidities in 4960 inpatients with chronic obstructive pulmonary disease in Beijing].
    Wei ZM; Cai JF; Cui H; Liu AM; Li Y; Gao F; Fan L
    Zhonghua Liu Xing Bing Xue Za Zhi; 2011 Mar; 32(3):297-301. PubMed ID: 21457669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease.
    Vanfleteren LE; Spruit MA; Groenen M; Gaffron S; van Empel VP; Bruijnzeel PL; Rutten EP; Op 't Roodt J; Wouters EF; Franssen FM
    Am J Respir Crit Care Med; 2013 Apr; 187(7):728-35. PubMed ID: 23392440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pattern of Cardiovascular Comorbidity in COPD in a Country with Low-smoking Prevalence: Results from Two-population-based Cohorts from Sweden.
    Eriksson B; Backman H; Ekerljung L; Axelsson M; Lindberg A; Rönmark E; Lundbäck B
    COPD; 2018 Oct; 15(5):454-463. PubMed ID: 30475654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of comorbidities according to predominant phenotype and severity of chronic obstructive pulmonary disease.
    Camiciottoli G; Bigazzi F; Magni C; Bonti V; Diciotti S; Bartolucci M; Mascalchi M; Pistolesi M
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2229-2236. PubMed ID: 27695310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Markers of Inflammation and Oxidative Stress in COPD Patients with or without Cardiovascular Comorbidities.
    Kaźmierczak M; Ciebiada M; Pękala-Wojciechowska A; Pawłowski M; Nielepkowicz-Goździńska A; Antczak A
    Heart Lung Circ; 2015 Aug; 24(8):817-23. PubMed ID: 25797323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is the impact of different spirometric criteria on the prevalence of spirometrically defined COPD and its comorbidities? Results from the population-based KORA study.
    Karrasch S; Brüske I; Smith MP; Thorand B; Huth C; Ladwig KH; Kronenberg F; Heinrich J; Holle R; Peters A; Schulz H
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1881-94. PubMed ID: 27574413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Prevalence of Metabolic Syndrome In Chronic Obstructive Pulmonary Disease: A Systematic Review.
    Cebron Lipovec N; Beijers RJ; van den Borst B; Doehner W; Lainscak M; Schols AM
    COPD; 2016 Jun; 13(3):399-406. PubMed ID: 26914392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-morbidity in mild-to-moderate COPD: comparison to normal and restrictive lung function.
    Lindberg A; Larsson LG; Rönmark E; Lundbäck B
    COPD; 2011 Dec; 8(6):421-8. PubMed ID: 22149402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent coexistence of chronic heart failure and chronic obstructive pulmonary disease in respiratory and cardiac outpatients: Evidence from SUSPIRIUM, a multicentre Italian survey.
    Griffo R; Spanevello A; Temporelli PL; Faggiano P; Carone M; Magni G; Ambrosino N; Tavazzi L;
    Eur J Prev Cardiol; 2017 Apr; 24(6):567-576. PubMed ID: 28067533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comorbidities and COPD severity in a clinic-based cohort.
    Raherison C; Ouaalaya EH; Bernady A; Casteigt J; Nocent-Eijnani C; Falque L; Le Guillou F; Nguyen L; Ozier A; Molimard M
    BMC Pulm Med; 2018 Jul; 18(1):117. PubMed ID: 30012144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic obstructive pulmonary disease as comorbidity in patients admitted to a university hospital: a cross-sectional study.
    Nielsen HM; Rødsgaard PA; Weinreich UM
    Clin Respir J; 2014 Jul; 8(3):274-80. PubMed ID: 23911061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular comorbidity in patients with chronic obstructive pulmonary disease in the Canary Islands (CCECAN study).
    Figueira Gonçalves JM; Dorta Sánchez R; Rodri Guez Pérez MDC; Viña Manrique P; Díaz Pérez D; Guzmán Saenz C; Palmero Tejera JM; Pérez Rodríguez A; Pérez Negrín L
    Clin Investig Arterioscler; 2017; 29(4):149-156. PubMed ID: 28390852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining the relationship between COPD and CVD: what are the implications for clinical practice?
    Morgan AD; Zakeri R; Quint JK
    Ther Adv Respir Dis; 2018; 12():1753465817750524. PubMed ID: 29355081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chronic obstructive pulmonary disease and cardiovascular system].
    Gürgün A; Gürgün C
    Tuberk Toraks; 2008; 56(4):464-71. PubMed ID: 19123087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet activation and cardiovascular comorbidities in patients with chronic obstructive pulmonary disease.
    Malerba M; Olivini A; Radaeli A; Ricciardolo FL; Clini E
    Curr Med Res Opin; 2016 May; 32(5):885-91. PubMed ID: 26824631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comorbidities of chronic obstructive pulmonary disease.
    Corsonello A; Antonelli Incalzi R; Pistelli R; Pedone C; Bustacchini S; Lattanzio F
    Curr Opin Pulm Med; 2011 Dec; 17 Suppl 1():S21-8. PubMed ID: 22209926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.